Nitrofur-C 75 mg tablets to be withdrawn from the market in 2025

The marketing authorisation holder Takeda Oy has announced that it will discontinue the marketing and sales of Nitrofur-C 75 mg film-coated tablets in Finland in 2025. There are no quality or safety reasons behind the withdrawal.

Nitrofur-C is the only medicinal product containing nitrofurantoin currently available in Finland. New marketing authorisations for medicinal products containing nitrofurantoin have been granted in 2024. Fimea has been in contact with the marketing authorisation holders of these products, but so far it is not known when these medicinal products might become available. 

Nitrofurantoin is a narrow-spectrum antibiotic used in the treatment of uncomplicated bacterial lower urinary tract infections. In most cases, there are other alternative antibiotics that can be used to treat infections in the lower urinary tract. Nitrofurantoin is used particularly in the treatment of infections caused by a strain of E. coli that is resistant to standard treatment. 

Information on the availability of medicinal products